Immunometabolism of tumor-associated macrophages: A therapeutic perspective
European Journal of Cancer · 2025-05 · 220 · 115332
DOI: 10.1016/j.ejca.2025.115332 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift European Journal of Cancer, 2025-05. Verfasst von Adelya F Karimova und 8 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Fundamental Medicine and Biology, Kazan Federal University, Kazan, Russia. Hauptthemen laut MEDLINE: Tumor-Associated Macrophages, Tumor Microenvironment, Neoplasms. Die Arbeit wurde bisher 66-mal zitiert (Crossref) und nennt 203 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Kazan Volga Region Federal University, German José Carreras Foundation for Leucemia, Swiss National Science Foundation.
Abstract (Originalsprache)
Tumor-associated macrophages (TAMs) play a pivotal role in the tumor microenvironment (TME), actively contributing to the formation of an immunosuppressive niche that fosters tumor progression. Consequently, there has been a growing interest in targeting TAMs as a promising avenue for cancer therapy. Recent advances in the field of immunometabolism have shed light on the influence of metabolic adaptations on macrophage physiology in the context of cancer. Here, we discuss the key metabolic pathways that shape the phenotypic diversity of macrophages. We place special emphasis on how metabolic reprogramming impacts the activation status of TAMs and their functions within the TME. Additionally, we explore alterations in TAM metabolism and their effects on phagocytosis, production of cytokines/chemokines and interaction with cytotoxic T and NK immune cells. Moreover, we examine the application of nanomedical approaches to target TAMs and assess the clinical significance of modulating the metabolism of TAMs as a strategy to develop new anti-cancer therapies. Taken together, in this comprehensive review article focusing on TAMs, we provide invaluable insights for the development of effective immunotherapeutic strategies and the enhancement of clinical outcomes for cancer patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute of Fundamental Medicine and Biology, Kazan Federal University, Kazan, Russia.
- Institute of Systems Immunology, Center for Tumor and Immune Biology, Philipps University of Marburg, Marburg, Germany.
- Institute of Pharmacology, University of Bern, Bern, Switzerland.
- Institute of Fundamental Medicine and Biology, Kazan Federal University, Kazan, Russia; Division of Medical and Biological Sciences, Tatarstan Academy of Sciences, Kazan, Russia.
- Institute of Fundamental Medicine and Biology, Kazan Federal University, Kazan, Russia; Institute of Pharmacology, University of Bern, Bern, Switzerland; Institute of Biochemistry, Brandenburg Medical School, Neuruppin,…
- Institute of Systems Immunology, Center for Tumor and Immune Biology, Philipps University of Marburg, Marburg, Germany. Electronic address: anna.brichkina@staff.uni-marburg.de.
Förderung
- Kazan Volga Region Federal University
- German José Carreras Foundation for Leucemia
- Swiss National Science Foundation
Zitieren
APA
Karimova, A. F., Khalitova, A. R., Suezov, R., Markov, N., Mukhamedshina, Y., Rizvanov, A. A., Huber, M., Simon, H. U., & Brichkina, A. (2025). Immunometabolism of tumor-associated macrophages: A therapeutic perspective. European Journal of Cancer, 220, 115332. https://doi.org/10.1016/j.ejca.2025.115332
Vancouver
Karimova AF, Khalitova AR, Suezov R, Markov N, Mukhamedshina Y, Rizvanov AA, et al. Immunometabolism of tumor-associated macrophages: A therapeutic perspective. European Journal of Cancer. 2025;220:115332. doi:10.1016/j.ejca.2025.115332
BibTeX
@article{Karimova2025,
author = {Karimova, Adelya F and Khalitova, Adelya R and Suezov, Roman and Markov, Nikita and Mukhamedshina, Yana and Rizvanov, Albert A and Huber, Magdalena and Simon, Hans-Uwe and Brichkina, Anna},
title = {Immunometabolism of tumor-associated macrophages: A therapeutic perspective},
journal = {European Journal of Cancer},
year = {2025},
volume = {220},
pages = {115332},
doi = {10.1016/j.ejca.2025.115332}
}
EUVIMED